Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tesamorelin Effects on Liver Fat and Histology in HIV: A Collaborative UO1 Grant

NCT02196831 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT02196831
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02196831 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tesamorelin Effects on Liver Fat and Histology in HIV: A Collaborative UO1 Grant
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Completed
Start date
July 1, 2015
Completion date
July 24, 2019
Enrollment
61 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

human immunodeficiency virus (hiv), nonalcoholic fatty liver disease (nafld), nonalcoholic steatohepatitis (nash)